Rinri Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.86M

  • Investors
  • 10

Rinri Therapeutics General Information

Description

Developer of regenerative medicine therapeutics intended to research and develop therapeutic candidates for sensory system disorders. The company's stem cell technology seeks to reverse sensorineural hearing loss through the repair of damaged or dead cytoarchitecture in the inner ear, enabling doctors to restore the hearing of patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Innovation Centre
  • 217 Portobello
  • Sheffield S1 4DP
  • England, United Kingdom
+44 0114
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Innovation Centre
  • 217 Portobello
  • Sheffield S1 4DP
  • England, United Kingdom
+44 0114

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rinri Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 13-May-2021 $3.86M Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 20-Apr-2021 Completed Clinical Trials - Phase 1
2. Seed Round 01-Mar-2021 $1.87M $1.87M Completed Clinical Trials - Phase 1
1. University Spin-Out 15-Nov-2018 Completed Startup
To view Rinri Therapeutics’s complete valuation and funding history, request access »

Rinri Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
To view Rinri Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rinri Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of regenerative medicine therapeutics intended to research and develop therapeutic candidates for sensory syst
Drug Discovery
Sheffield, United Kingdom
19 As of 2026

San Diego, CA
 

Tubingen, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rinri Therapeutics Competitors (14)

One of Rinri Therapeutics’s 14 competitors is Neurelis, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurelis Venture Capital-Backed San Diego, CA
Acousia Therapeutics Venture Capital-Backed Tubingen, Germany
Oricula Therapeutics Formerly Accelerator/Incubator backed Seattle, WA
Sensorion Formerly VC-backed Montpellier, France
Autifony Therapeutics Formerly VC-backed Stevenage, United Kingdom
You’re viewing 5 of 14 competitors. Get the full list »

Rinri Therapeutics Patents

Rinri Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023348283-A1 Laminin cell culture substrate and protocol Pending 29-Sep-2022
EP-4594476-A1 Laminin cell culture substrate and protocol Active 29-Sep-2022
EP-4594476-B1 Laminin cell culture substrate and protocol Active 29-Sep-2022
US-20260337558-A1 Laminin cell culture substrate and protocol Pending 29-Sep-2022
WO-2024068934-A1 Laminin cell culture substrate and protocol Inactive 29-Sep-2022 C12N5/0623
To view Rinri Therapeutics’s complete patent history, request access »

Rinri Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rinri Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority
Government of UK Government Minority
The Future Fund Hedge Fund Minority
Alderley Park Accelerator/Incubator Minority
You’re viewing 5 of 10 investors. Get the full list »

Rinri Therapeutics FAQs

  • When was Rinri Therapeutics founded?

    Rinri Therapeutics was founded in 2018.

  • Where is Rinri Therapeutics headquartered?

    Rinri Therapeutics is headquartered in Sheffield, United Kingdom.

  • What is the size of Rinri Therapeutics?

    Rinri Therapeutics has 19 total employees.

  • What industry is Rinri Therapeutics in?

    Rinri Therapeutics’s primary industry is Drug Discovery.

  • Is Rinri Therapeutics a private or public company?

    Rinri Therapeutics is a Private company.

  • What is Rinri Therapeutics’s current revenue?

    The current revenue for Rinri Therapeutics is .

  • How much funding has Rinri Therapeutics raised over time?

    Rinri Therapeutics has raised $21.2M.

  • Who are Rinri Therapeutics’s investors?

    Innovate UK, Boehringer Ingelheim Venture Fund, Government of UK, The Future Fund, and Alderley Park are 5 of 10 investors who have invested in Rinri Therapeutics.

  • Who are Rinri Therapeutics’s competitors?

    Neurelis, Acousia Therapeutics, Oricula Therapeutics, Sensorion, and Autifony Therapeutics are some of the 14 competitors of Rinri Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process